INmune Bio Inc.
INMB
$2.17
$0.094.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.27M | -5.41M | -5.26M | -6.47M | -24.46M |
| Total Depreciation and Amortization | 66.00K | 52.00K | 56.00K | 28.00K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.36M | 1.41M | 3.32M | 2.36M | 18.05M |
| Change in Net Operating Assets | -3.33M | 546.00K | -1.05M | -1.35M | -965.00K |
| Cash from Operations | -3.18M | -3.40M | -2.94M | -5.44M | -7.38M |
| Capital Expenditure | -430.00K | -- | -143.00K | -193.00K | -706.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -430.00K | -- | -143.00K | -193.00K | -706.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 749.00K | -- | 0.00 | 0.00 | 22.27M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 67.00K | -- | -- |
| Cash from Financing | 749.00K | -- | 67.00K | 0.00 | 22.27M |
| Foreign Exchange rate Adjustments | -91.00K | 10.00K | 37.00K | -8.00K | -153.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.95M | -3.39M | -2.98M | -5.64M | 14.04M |